These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26772157)
1. In vitro anticancer activity of Betulinic acid and derivatives thereof on equine melanoma cell lines from grey horses and in vivo safety assessment of the compound NVX-207 in two horses. Liebscher G; Vanchangiri K; Mueller T; Feige K; Cavalleri JM; Paschke R Chem Biol Interact; 2016 Feb; 246():20-9. PubMed ID: 26772157 [TBL] [Abstract][Full Text] [Related]
2. Potent drug delivery enhancement of betulinic acid and NVX-207 into equine skin in vitro - a comparison between a novel oxygen flow-assisted transdermal application device and microemulsion gels. Zscherpe P; Kalbitz J; Weber LA; Paschke R; Mäder K; von Rechenberg B; Cavalleri JV; Meißner J; Klein K BMC Vet Res; 2024 May; 20(1):202. PubMed ID: 38755639 [TBL] [Abstract][Full Text] [Related]
3. Concentration profiles and safety of topically applied betulinic acid and NVX-207 in eight healthy horses-A randomized, blinded, placebo-controlled, crossover pilot study. Weber LA; Puff C; Kalbitz J; Kietzmann M; Feige K; Bosse K; Rohn K; Cavalleri JV J Vet Pharmacol Ther; 2021 Jan; 44(1):47-57. PubMed ID: 32845519 [TBL] [Abstract][Full Text] [Related]
4. In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer. Weber LA; Funtan A; Paschke R; Delarocque J; Kalbitz J; Meißner J; Feige K; Kietzmann M; Cavalleri JV PLoS One; 2020; 15(11):e0241448. PubMed ID: 33151949 [TBL] [Abstract][Full Text] [Related]
5. Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization. Bache M; Bernhardt S; Passin S; Wichmann H; Hein A; Zschornak M; Kappler M; Taubert H; Paschke R; Vordermark D Int J Mol Sci; 2014 Oct; 15(11):19777-90. PubMed ID: 25361208 [TBL] [Abstract][Full Text] [Related]
6. Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in vitro. Weber LA; Meißner J; Delarocque J; Kalbitz J; Feige K; Kietzmann M; Michaelis A; Paschke R; Michael J; Pratscher B; Cavalleri JV BMC Vet Res; 2020 Feb; 16(1):44. PubMed ID: 32024502 [TBL] [Abstract][Full Text] [Related]
7. Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound. Willmann M; Wacheck V; Buckley J; Nagy K; Thalhammer J; Paschke R; Triche T; Jansen B; Selzer E Eur J Clin Invest; 2009 May; 39(5):384-94. PubMed ID: 19309323 [TBL] [Abstract][Full Text] [Related]
8. New ionic derivatives of betulinic acid as highly potent anti-cancer agents. Suresh C; Zhao H; Gumbs A; Chetty CS; Bose HS Bioorg Med Chem Lett; 2012 Feb; 22(4):1734-8. PubMed ID: 22264477 [TBL] [Abstract][Full Text] [Related]
9. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977 [TBL] [Abstract][Full Text] [Related]
10. Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells. Kommera H; Kaluđerović GN; Kalbitz J; Paschke R Invest New Drugs; 2011 Apr; 29(2):266-72. PubMed ID: 19957199 [TBL] [Abstract][Full Text] [Related]
11. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Tan Y; Yu R; Pezzuto JM Clin Cancer Res; 2003 Jul; 9(7):2866-75. PubMed ID: 12855667 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of betulinic acid derivatives with activity against human melanoma. Kim DS; Pezzuto JM; Pisha E Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420 [TBL] [Abstract][Full Text] [Related]
13. Betulinic Acid and its Derivatives as Potential Antitumor Agents. Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity. Denner TC; Heise NV; Hoenke S; Csuk R Molecules; 2024 May; 29(10):. PubMed ID: 38792206 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment. Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674 [TBL] [Abstract][Full Text] [Related]
16. Preparation of amino acid conjugates of betulinic acid with activity against human melanoma. Jeong HJ; Chai HB; Park SY; Kim DS Bioorg Med Chem Lett; 1999 Apr; 9(8):1201-4. PubMed ID: 10328313 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents. Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774 [TBL] [Abstract][Full Text] [Related]
18. Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status. Rieber M; Rieber MS Int J Cancer; 2006 Mar; 118(5):1135-43. PubMed ID: 16152620 [TBL] [Abstract][Full Text] [Related]
19. Betulinic acid sensitization of low pH adapted human melanoma cells to hyperthermia. Wachsberger PR; Burd R; Wahl ML; Leeper DB Int J Hyperthermia; 2002; 18(2):153-64. PubMed ID: 11911485 [TBL] [Abstract][Full Text] [Related]
20. Development of C-20 modified betulinic acid derivatives as antitumor agents. Kim JY; Koo HM; Kim DS Bioorg Med Chem Lett; 2001 Sep; 11(17):2405-8. PubMed ID: 11527742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]